Intellia Therapeutics Inc buy Truist Financial Co.
Start price
24.06.24
/
50%
€23.43
Target price
24.06.25
€111.85
Performance (%)
-64.98%
End price
25.06.25
€8.21
Summary
This prediction ended on 25.06.25 with a price of €8.21. The BUY prediction by Truist_Financial_Co_ for Intellia Therapeutics Inc performed very badly with a performance of -64.98%. Truist_Financial_Co_ has a follow-up prediction for Intellia Therapeutics Inc where he still thinks Intellia Therapeutics Inc is a Buy. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -6.699% | -6.699% | -37.471% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $120.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Truist_Financial_Co_ for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€8.43
04.03.25
04.03.25
€47.44
04.03.26
04.03.26
-7.85%
21:38
21:38
Stopped prediction by Truist_Financial_Co_ for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€8.65
10.11.25
10.11.25
€12.11
10.11.26
10.11.26
-10.13%
21:38
21:38